Five‐year survival post hepatectomy for colorectal liver metastases in a real‐world Chinese cohort: Recurrence patterns and prediction for potential cure
Cancer Medicine · 2023-04 · 12 (8) · 9559-9569
DOI: 10.1002/cam4.5732 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 27.02.2023. Verfasst von Yu-Ming Su und 11 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Hepatopancreatobiliary Surgery Department I, Peking Univ…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Liver Neoplasms. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Capital Foundation of Medical Development, National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
Background
Patients with a 5‐year recurrence‐free survival post liver resection for colorectal cancer liver metastases (CRLM) are considered to be potentially cured. However, there is a deficit of data on long‐term follow‐up and the recurrence status among these patients in the Chinese population. We analyzed real‐world follow‐up data of patients with CRLM who underwent hepatectomy, explored the recurrence patterns, and established a prediction model for a potential cure scenario.
Methods
Patients who underwent radical hepatic resection for CRLM during 2000–2016, with actual follow‐up data for at least 5 years, were enrolled. The observed survival rate was calculated and compared among the groups with different recurrence patterns. The predictive factors for 5‐year non‐recurrence were determined using logistic regression analysis; a recurrence‐free survival model was developed to predict long‐term survival.
Results
A total of 433 patients were included, of whom 113 patients were found non‐recurrence after 5 years follow‐up, with a potential cure rate of 26.1%. Patients with late recurrence (>5 months) and lung relapse showed significantly superior survival. Repeated localized treatment significantly improved the long‐term survival of patients with intrahepatic or extrahepatic recurrences. Multivariate analysis showed that RAS wild‐type CRC, preoperative CEA
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Hepatopancreatobiliary Surgery Department I, Peking University Cancer Hospital & Institute, Beijing, China.
ORCID-Profile: Yu-Ming Su, Wei Liu, Xiao-Luan Yan, Li-Jun Wang, Ming Liu, Hong-Wei Wang, Ke-Min Jin, Quan Bao, Kun Wang, Juan Li, Da Xu, Bao-Cai Xing
Förderung
- Capital Foundation of Medical Development
- National Natural Science Foundation of China
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Su, Y. M., Liu, W., Yan, X. L., Wang, L. J., Liu, M., Wang, H. W., Jin, K. M., Bao, Q., Wang, K., Li, J., Xu, D., & Xing, B. C. (2023). Five‐year survival post hepatectomy for colorectal liver metastases in a real‐world Chinese cohort: Recurrence patterns and prediction for potential cure. Cancer Medicine, 12(8), 9559-9569. https://doi.org/10.1002/cam4.5732
Vancouver
Su YM, Liu W, Yan XL, Wang LJ, Liu M, Wang HW, et al. Five‐year survival post hepatectomy for colorectal liver metastases in a real‐world Chinese cohort: Recurrence patterns and prediction for potential cure. Cancer Medicine. 2023;12(8):9559-9569. doi:10.1002/cam4.5732
BibTeX
@article{Su2023,
author = {Su, Yu-Ming and Liu, Wei and Yan, Xiao-Luan and Wang, Li-Jun and Liu, Ming and Wang, Hong-Wei and Jin, Ke-Min and Bao, Quan and Wang, Kun and Li, Juan and Xu, Da and Xing, Bao-Cai},
title = {Five‐year survival post hepatectomy for colorectal liver metastases in a real‐world Chinese cohort: Recurrence patterns and prediction for potential cure},
journal = {Cancer Medicine},
year = {2023},
volume = {12},
number = {8},
pages = {9559--9569},
doi = {10.1002/cam4.5732}
}
EUVIMED